PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Oct-2021 bit.bio product launch: ioSkeletal Myocytes; the first supply of consistent, scalable, human muscle cells provide transformative new models for research and drug discovery bit.bio
14-Oct-2021 New Research Results at the Rotterdam Microbiome R&D & Business Collaboration Forum Europe BELANO medical AG
14-Oct-2021 Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox Topelia Aust Pty Ltd
13-Oct-2021 Synaffix to Present Key ADC Technology Data on SYNtecan E™ Linker-Payload at World ADC Conference Synaffix
13-Oct-2021 Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s COVID-19 Vaccine for Low Income Countries in First Half of 2022 Moderna
13-Oct-2021 BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery BD
13-Oct-2021 ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC) ImmunOs Therapeutics
12-Oct-2021 HCL Partners with Google Cloud to Launch Innovative Healthcare & Life Sciences Solutions HCL Technologies
12-Oct-2021 Pistoia Alliance Sets Out Plans to Tackle Emerging Tech, R&D Efficiency, and Patient Empowerment with New Strategic Themes The Pistoia Alliance
12-Oct-2021 Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging Rejuveron
11-Oct-2021 Tegsedi® Receives Innovative Drug Category Pricing in Brazil PTC Therapeutics
11-Oct-2021 CD Formulation Releases Crystallinity Determination Service for API Development CD Formulation
08-Oct-2021 Quality deemed more critical than price as companies progress with PV case intake automation, 2021 Arriello UK/US survey finds Arriello
07-Oct-2021 Moderna Announces the Launch of Global Fellowship Program for Young Researchers Exploring mRNA Medicines Moderna
07-Oct-2021 Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year Moderna
06-Oct-2021 Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older Moderna
06-Oct-2021 Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality Revax Biotech
05-Oct-2021 Novavax Announces Leadership Appointment and Updates Novavax
01-Oct-2021 Moderna to Invest in New Science Center in Cambridge, MA Moderna
01-Oct-2021 Macomics Announces New Hires that Expands its Macrophage-based Drug Discovery R&D Team Macomics